GeneDx Holdings (WGS) reported a Q1 loss Wednesday of $0.23 per share, narrowing from a loss of $0.78 a year earlier.
Two analysts polled by FactSet expected a loss of $0.27 per share.
Revenue for the quarter ended March 31 was $87.1 million, up from $62.4 million a year earlier.
Analysts surveyed by FactSet expected $79.5 million.
The company said it now expects full-year revenue of $360 million to $375 million compared with its prior guidance of $350 million to $360 million. Analysts polled by FactSet expect $358.9 million.
Shares of the company were down more than 27% in recent Wednesday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.